| Literature DB >> 29454981 |
Andreas Koeberle1, Oliver Werz2.
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit prostanoid formation and represent prevalent therapeutics for treatment of inflammatory disorders. However, NSAIDs are afflicted with severe side effects, which might be circumvented by more selective suppression of pro-inflammatory eicosanoid biosynthesis. This concept led to dual inhibitors of microsomal prostaglandin E2 synthase (mPGES)-1 and 5-lipoxygenase that are crucial enzymes in the biosynthesis of pro-inflammatory prostaglandin E2 and leukotrienes. The potential of their dual inhibition in light of superior efficacy and safety is discussed. Focus is placed on natural products, for which direct inhibition of mPGES-1 and leukotriene biosynthesis has been confirmed.Entities:
Keywords: 5-Lipoxygenase; 5-Lipoxygenase-activating protein; Arachidonic acid; Cyclooxygenase; Eicosanoid; Leukotriene; Microsomal prostaglandin E(2) synthase-1; Natural product; Polypharmacology; Prostaglandin
Mesh:
Substances:
Year: 2018 PMID: 29454981 DOI: 10.1016/j.biotechadv.2018.02.010
Source DB: PubMed Journal: Biotechnol Adv ISSN: 0734-9750 Impact factor: 14.227